This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
SureNano Science advances GEP-44 toward FDA approval with LabCorp partnership, initiating IND-enabling studies for its GLP-1 agonist targeting obesity and Type II diabetes. #Biotech #FDA
2026-05-15T04:08:04.374Z